Select Topic
Myelodysplastic Syndrome (MDS) is a group of bone marrow disorders that affect the body’s ability to produce blood cells. In this condition, the bone marrow becomes dysfunctional, resulting in the production of abnormal blood cells that do not work properly. The symptoms depend on which blood cells MDS affects and how much their levels have declined. Early recognition and appropriate medical care are important for long-term management.
Although doctors more commonly diagnose MDS in older adults, people often mistake its symptoms for normal aging or other common health conditions. Early recognition is important, as some forms of MDS can progress over time and affect overall health and quality of life. With advances in diagnostic testing and personalized treatment strategies, many patients can effectively manage the condition and maintain their daily activities with appropriate medical care.
In MDS, the bone marrow remains active but produces abnormal blood cells that fail to mature properly. Many of these cells are either defective or destroyed before entering the bloodstream, resulting in ineffective blood cell production.
This disruption affects all major blood cell lines. A reduction in healthy red blood cells can lead to anemia, while impaired white blood cell production weakens the immune system. Low platelet levels may also affect the body’s ability to control bleeding. Over time, this imbalance in blood cell production contributes to the clinical features of MDS.
The symptoms depend on which blood cells MDS affects and how severely their levels decline.
Because MDS interferes with the bone marrow’s ability to produce healthy blood cells, symptoms may develop gradually and often resemble those of other common health conditions.
Common signs and symptoms of MDS include:
Because many other conditions can cause these symptoms, doctors need to perform a medical evaluation to determine the underlying cause and establish an accurate diagnosis.
The exact cause of MDS is often unknown. In many cases, MDS develops when genetic changes occur in the bone marrow cells that produce blood cells. These changes can disrupt normal blood cell development, causing the bone marrow to produce abnormal cells that do not mature or function properly.
Several factors may increase the risk of developing the condition of MDS, including:
While these factors may increase risk, many people diagnosed with MDS have no identifiable cause. Although researchers still need to learn much about MDS, ongoing research is providing valuable insights into the genetic and environmental factors that may cause its development.
MDS can lead to several health complications as the bone marrow becomes less effective at producing healthy blood cells. These complications are mainly related to low levels of red blood cells, white blood cells, and platelets, and their severity may vary depending on the condition.
Common complications include:
Because MDS can progress over time, regular monitoring and ongoing medical care are important for managing symptoms and detecting early changes.
Doctors made the diagnosis using laboratory tests and a bone marrow examination. These tests help ensure the diagnosis and evaluate how well the bone marrow produces blood cells, since symptoms may resemble those of other hematologic conditions.
After doctors confirm the diagnosis, they evaluate the severity of the disease, blood counts, and the risk of progression. They use this overall evaluation to determine the most appropriate treatment for each patient, with the goals of improving blood counts, managing symptoms, and reducing complications.
Doctors individualize treatment based on disease severity, blood cell counts, symptom burden, overall health, and the risk of disease progression. The goals of treatment are to improve bone marrow function, enhance blood cell production, manage symptoms, and reduce the risk of complications.
Supportive and Medical Treatments
Treatments vary from one patient to another, depending on the type of MDS and the patient’s condition. The goal of treatment is to manage symptoms, improve blood cell counts, and maintain quality of life.
Bone Marrow Transplantation
For some patients with higher-risk MDS, bone marrow transplantation offers the best opportunity for long-term disease control and potential cure. Unlike other treatments that primarily manage symptoms or improve blood counts, bone marrow transplantation aims to replace diseased bone marrow that produces abnormal blood cells.
The treatment involves replacing diseased bone marrow with healthy blood-forming cells from a compatible donor, enabling the body to establish new, more effective blood cell production. Because bone marrow transplantation is an intensive treatment, doctors determine eligibility based on several factors, including disease risk, age, overall health, and tolerance for the procedure. For carefully selected patients, it remains the only treatment with curative potential for MDS.
Patients should not ignore persistent fatigue, frequent infections, easy bruising, or unusual bleeding, especially when symptoms continue to worsen or do not have a clear explanation. While these symptoms can be related to a variety of conditions, they may also be signs of an underlying bone marrow disorder such as MDS.
At Vejthani International Hospital’s Life Cancer Center, care for patients with Myelodysplastic Syndrome (MDS) is guided by a multidisciplinary team experienced in diagnosing and treating complex blood disorders. Using advanced diagnostic technologies and individualized treatment, the Life Cancer Center works closely with each patient to develop a care plan personalized to their individual needs.
Because MDS can affect each patient differently, early diagnosis and appropriate treatment planning are essential. With expert evaluation, ongoing monitoring, and individualized care, many patients can achieve better symptom control, improved quality of life, and more effective long-term disease management.
MDS is a group of disorders in which the bone marrow does not produce sufficiently healthy blood cells. This leads to low levels of red blood cells, white blood cells, or platelets, which can cause fatigue, infections, or easy bleeding.
MDS is considered a type of blood cancer in many cases because it involves abnormal bone marrow function and has the potential to progress to acute myeloid leukemia (AML). However, the severity and progression vary widely between patients.
Early symptoms may be mild and develop slowly. Common signs include persistent fatigue, frequent infections, shortness of breath, and easy bruising or bleeding. Some patients may have no symptoms at the early stage and are diagnosed through routine blood tests.
Treatment depends on disease severity and patient condition. Options may include supportive care, blood transfusions, growth factor therapy, medications, and, in some cases, bone marrow transplantation, which may offer the potential for long-term disease control or cure.
In most cases, MDS cannot be completely cured. However, some patients may achieve long-term disease control. Bone marrow transplantation is the treatment that offers a potential cure for selected patients.
